To simulate this clinical scenario and determine the functional role of PPARγ in HCC, we used the poorly differentiated and relatively low PPARγ-expressing HCC cell line Mahlavu to overexpress PPARγ. This evidence concerns the gene PPARG and hepatocellular carcinoma.